Table 1 Baseline characteristics of the patients
Variable | TACE-Iodine-125 (n = 34) (%) | TACE (n = 35) (%) | p Value |
|---|---|---|---|
Sex | 0.163† | ||
Male | 29(85) | 25(71) | |
Female | 5(15) | 10(29) | |
Age (y) (mean ± SD) | 58.1 ± 7.3 | 54.5 ± 8.4 | 0.061‡ |
ECOG performance | 0.729† | ||
0 | 15(44) | 14(40) | |
1–2 | 19(56) | 21(60) | |
Cause of liver disease | |||
HBV | 31(91.2) | 33(94.4) | 0.973§ |
HCV | 2(5.9) | 1(2.8) | 0.980§ |
Other | 1(2.9) | 1(2.8) | |
Child-Pugh score | 0.627§ | ||
A | 33(97) | 32(91.4) | |
B | 1(3) | 3(8.6) | |
Largest tumor diameter (cm) (mean ± SD) | 7.6 ± 3.0 | 8.7 ± 2.5 | 0.119‡ |
Number of tumors | 0.956† | ||
Single | 17(45.9) | 20(54.1) | |
Multiple | 18(56.2) | 14(43.8) | |
Extrahepatic spread | 3(9) | 4(11) | 1.000§ |
AFP level (ng/mL) | 0.032†* | ||
≤ 400 | 15(44) | 7(20) | |
> 400 | 19(56) | 28(80) | |
ALT (u/l) (Mean ± SD) | 42.9 ± 23.6 | 46.5 ± 30.3 | 0.584§§ |
TBIL (μmol/L) (Mean ± SD) | 16.4 ± 7.8 | 20.1 ± 10.1 | 0.067§§ |
Albumin (g/L) (Mean ± SD) | 37.2 ± 4.6 | 34.7 ± 6.2 | 0.114§§ |
Type of PVTT | 0.722† | ||
VP1 + VP2 | 17(50) | 16(46) | |
VP3 | 17(50) | 19(54) | |